FDA narrows search for new CBER chief to three or four finalists
read at Endpoints ↗RegulatoryNeutral
The FDA announced that its search for a new head of the Center for Biologics Evaluation and Research (CBER) has been narrowed.
According to a source familiar with the process, the agency is now focusing on a small pool of three to four final candidates.
The selection is expected to shape the leadership of the biologics regulatory unit, though no timeline or names were disclosed.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “FDA search for new CBER head focused on small group of final candidates”
read at Endpoints ↗113 words · retrieved May 4
comments(0)
5-min edit window · permanent after that